Improved recombinant Api m 1- and Ves v 5-based IgE testing to dissect bee and yellow jacket allergy and their correlation with the severity of the sting reaction

2016 ◽  
Vol 46 (4) ◽  
pp. 621-630 ◽  
Author(s):  
J. Šelb ◽  
R. Kogovšek ◽  
M. Šilar ◽  
M. Košnik ◽  
P. Korošec
Keyword(s):  
Yellow Jacket ◽  
Sting Reaction ◽  
Ves V 5

scholarly journals 1462 Yellow Jacket in the Colon: An Incidental Finding During Screening Colonoscopy

2019 ◽  
Vol 114 (1) ◽  
pp. S810-S811
Author(s):  
Narasimha Swamy Gollol Raju ◽  
Eslam Aboutaleb ◽  
Muhammad Ali ◽  
Eslam Ali
Keyword(s):  
Incidental Finding ◽  
Screening Colonoscopy ◽  
Yellow Jacket

Protein allergens of white-faced hornet, yellow hornet, and yellow jacket venoms

Biochemistry ◽  
1978 ◽  
Vol 17 (24) ◽  
pp. 5165-5174 ◽  
Author(s):  
T. P. King ◽  
A. K. Sobotka ◽  
A. Alagon ◽  
L. Kochoumian ◽  
L. M. Lichtenstein
Keyword(s):  
Yellow Jacket

Immunotherapy with honeybee venom and yellow jacket venom is different regarding efficacy and safety

1992 ◽  
Vol 89 (2) ◽  
pp. 529-535 ◽  
Author(s):  
U MULLER ◽  
A HELBLING ◽  
E BERCHTOLD
Keyword(s):  
Efficacy And Safety ◽  
Honeybee Venom ◽  
Yellow Jacket ◽  
Yellow Jacket Venom

Yellow jacket sting

2004 ◽  
pp. 624-624
Keyword(s):  
Yellow Jacket

scholarly journals Fatal Anaphylactic Sting Reaction in a Patient with Mastocytosis

2008 ◽  
Vol 146 (2) ◽  
pp. 162-163 ◽  
Author(s):  
N. Wagner ◽  
D. Fritze ◽  
B. Przybilla ◽  
M. Hagedorn ◽  
F. Ruëff
Keyword(s):  
Sting Reaction

scholarly journals Benefits of venom immunotherapy: How soon can they be expected

2017 ◽  
Vol 145 (3-4) ◽  
pp. 173-177
Author(s):  
Sasa Kadivec ◽  
Mitja Kosnik
Keyword(s):  
First Year ◽  
Severe Reaction ◽  
Allergic Reactions ◽  
Venom Immunotherapy ◽  
Emergency Situations ◽  
Sting Reaction ◽  
Life Threatening ◽  
Medical Emergencies ◽  
The Cost ◽  
Patients Experience

Introduction/Objective. Allergic reactions to insect stings are medical emergencies that could be prevented by venom immunotherapy (VIT). The main purpose of VIT is to prevent fatal or life-threatening reactions. We aimed to show the rapidity with which patients experience the benefits of VIT and estimate the number of emergency treatments that are prevented. Methods. We reviewed the medical files of patients who started VIT between 2010 and 2014. We calculated the costs of treatment of the sting reactions, the costs of immunotherapy, and estimated the costs of prevented allergic reactions. Results. In a cohort of 514 patients (40.9% female, age 47.2 ? 14.4 years), the cost of treatment of the index sting reaction was 180.4 ? 166.8 euros. During VIT, 195 patients experienced 446 field stings. In 86.3% of patients, stings were well tolerated, and only one patient experienced a severe reaction (grade III, according to Mueller). A total of 20.4% of VIT treated patients were stung during the first year of VIT and 57% during five years of VIT. The expenditure for five years of VIT was 2,886 euros per patient, which corresponded to an average of 16 emergency treatments for systemic reactions. Conclusion. Emergency situations are prevented in a substantial number of venom-allergic patients and a beneficial effect was already observed during the first year of VIT.

Sign in / Sign up

Export Citation Format

Share Document